Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

ALPMYALPMY
13 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in Astellas Pharma Inc

RHUMBLINE ADVISERS holds 21,642 shares of ALPMY (Astellas Pharma Inc), worth $289,348 as of 2026-Q2. The position was decreased (-0.7% shares). ALPMY represents 0.0% of RHUMBLINE ADVISERS's portfolio.

Current Value

$289,348

Current Shares

21,642

Total Value Change

-$227,295

Total Shares Change

-13,102

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
21,642
-0.7%
$289,3480.0%$13.37
0
2026-Q1
Decreased
21,804
-6.8%
$353,6570.0%$16.22
0
2025-Q4
Decreased
23,408
-5.8%
$311,0870.0%$13.29
0
2025-Q3
Decreased
24,846
-20.2%
$270,3200.0%$10.88
0
2025-Q2
Decreased
31,138
-8.1%
$303,5920.0%$9.75
0
2025-Q1
Decreased
33,873
-5.8%
$327,2090.0%$9.66
0
2024-Q4
Decreased
35,945
-2.4%
$347,2240.0%$9.41
0
2024-Q3
Increased
36,828
+9.7%
$421,6750.0%$11.15
26
2024-Q2
Decreased
33,588
-11.4%
$331,1730.0%$9.40
0
2024-Q1
Increased
37,924
+10.1%
$407,6790.0%$10.25
26
2023-Q4
Decreased
34,439
-0.9%
$409,8200.0%$11.35
0
2023-Q3
Increased
34,759
+0.0%
$481,4080.0%$13.21
24
2023-Q2
New
34,744
-
$516,6430.0%$14.18
33

Other major holders of ALPMY: GLENMEDE TRUST CO NA, Aristotle Capital Management, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used